Kaposi's sarcoma, biologics and small molecules: Navigating the complex interplay between host immunity and viral biology. A case series with focused review of the literature-Reference-Cited by-同舟云学术

Kaposi's sarcoma, biologics and small molecules: Navigating the complex interplay between host immunity and viral biology. A case series with focused review of the literature

Published:2021-12-27 Issue: Volume: Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Brambilla Lucia¹,Maronese Carlo Alberto¹²^ORCID,Zelin Enrico³^ORCID,Genovese Giovanni¹²^ORCID,Tourlaki Athanasia¹

Affiliation:

1. Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

2. Department of Pathophysiology and Transplantation Università degli Studi di Milano Milan Italy

3. Dermatology Clinic, Maggiore Hospital University of Trieste Trieste Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15278

Reference67 articles.

1. Kaposi sarcoma: A continuing conundrum

2. The world‐wide incidence of Kaposi's sarcoma in the HIV / AIDS era

3. KSHV: Immune Modulation and Immunotherapy

4. Iatrogenic Kaposi's Sarcoma: a Retrospective Cohort Study in an Italian Tertiary Care Centre

5. PD ‐L1 expression in tumour microenvironment supports the rationale for immune checkpoint blockade in classic Kaposi's sarcoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kaposi's sarcoma: epidemiologic aspects, the immune reconstitution inflammatory syndrome, and more along the Silk Road of cognition;Italian Journal of Dermatology and Venereology;2023-12

2. Valganciclovir modulates the tumor necrosis factor axis molecules expression and CD4+ T-cell subsets in disseminated Kaposi Sarcoma patients;Clinical and Experimental Immunology;2023-10-31

3. Iatrogenes Kaposi‐Sarkom unter Vedolizumab bei Colitis ulcerosa;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-04

4. Multiple drugs;Reactions Weekly;2022-05